Home Dazheng Medical Reports 2020 Net Profit of RMB 25.85 Million, Up 10.49% Year-over-Year

Dazheng Medical Reports 2020 Net Profit of RMB 25.85 Million, Up 10.49% Year-over-Year

Mar 24, 2021 19:35 CST Updated 19:35
GRED

Medical Device R&D, Production, and Sales Company

Source: Wabei.com

Wabei.com, March 24GRED(430496) Recently released its 2020 annual report. During the reporting period, the company achieved operating revenue of RMB 101,077,864.11, a year-on-year decrease of 3.26%; the net profit attributable to shareholders of the listed company was RMB 25,853,420.10, a year-on-year increase of 10.49%.

During the reporting period, the net cash flow from operating activities amounted to RMB 35,612,515.85. As of the end of 2020, the net assets attributable to shareholders of the listed company were RMB 179,550,858.34.

During the reporting period, operating revenue amounted to RMB 101,077,864.11, representing a year-on-year decrease of 3.26%, primarily attributable to a decline in sales revenue from sanitary material products.

During the reporting period, credit impairment losses amounted to RMB 2,860,800.28, representing a year-on-year increase of 173.70%. This was primarily attributable to the year-on-year increase in the balance of accounts receivable and the write-off of certain bad debts during the current period.

Financial expenses during the period amounted to -64,448.22 yuan, compared to -281,222.22 yuan in the same period last year, primarily due to a decrease in interest income from bank deposits during the reporting period. Investment income during the period was 576,583.08 yuan, compared to 1,053,318.68 yuan in the same period last year, representing a year-on-year decrease of 45.26%, mainly attributable to a reduction in the amount invested in principal-guaranteed bank wealth management products purchased during the reporting period.

According to data from Wabei.com, GRED is a high-tech enterprise integrating research and development, production, sales, and services, with medical devices as its core business. The company’s main operations include the production and sale of medical devices such as disposable external cranial drainage systems and neonatal umbilical cord ligation protection bands.